| Sep 17 |
Dermata Therapeutics prices $3.5M equity offering
|
| Sep 17 |
Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
|
| Sep 16 |
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
|
| Sep 5 |
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
|
| Aug 9 |
7 F-Rated Growth Stocks to Avoid Like the Plague in August 2024
|
| Aug 8 |
Dermata Therapeutics GAAP EPS of -$4.18
|
| Aug 7 |
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
|
| Aug 7 |
Peering Into Dermata Therapeutics's Recent Short Interest
|
| Jul 24 |
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
|
| Jul 17 |
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
|
